Activated Protein C to Treat Acute Lung Injuries
Clinical and Biological Markers in Acute Respiratory Failure
Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)
Hemodynamics and Extravascular Lung Water in Acute Lung Injury
Abnormalities in Lung Computed Tomography and Physiological Alterations in Patients With Acute Respiratory Distress Syndrome
Postoperative Pulmonary Complications in Abdominal Surgery
† Study has passed its completion date and status has not been verified in more than two years.